FDA
-
-
-
-
-
-
-
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
CorMedix Announces Strategic Minority Investment in Talphera
-
-
-
-
-
-
-
CorMedix to acquire Melinta Therapeutics for $300 million
-
-
-
-
-
-
-
H.C. Wainwright Initiates Buy Rating on CorMedix (CRMD)
-
-
-
-
-
-
-
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
-
-
-
-
-
-
CorMedix Inc. Added to Nasdaq Biotechnology Index
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

